Mother and Child: Medication Use in Pregnancy and Lactation

Pregnancy and breastfeeding pose a unique challenge to drug development and clinical application. In addition to drug toxicity to the fetus in utero and infants through breastfeeding, alterations of pharmacokinetics in those women also need careful attention. How do we turn around the overall lack of drug efficacy and toxicity information for pregnant and breastfeeding women?

[1]  G. Bandoli,et al.  Maternal use of selective serotonin‐reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn , 2016, Clinical pharmacology and therapeutics.

[2]  M. Hebert,et al.  Pregnancy‐related pharmacokinetic changes , 2016, Clinical pharmacology and therapeutics.

[3]  P. Anderson,et al.  Modeling drug passage into human milk , 2016, Clinical pharmacology and therapeutics.

[4]  L. Schuler‐Faccini,et al.  Zika virus: A new human teratogen? Implications for women of reproductive age , 2016, Clinical pharmacology and therapeutics.

[5]  H. Taussig.  Thalidomide and phocomelia. , 1962, Pediatrics.